Abstract：
BACKGROUND:Language disturbances have been previously described as word-finding difficulties in epileptic patients. These disturbances have been recently reported in migraineurs in treatment with topiramate but they have never been defined and assessed in these patients with the aid of neuropsychological testing. OBJECTIVE:To verify the occurrence of language disturbances as a side effect of topiramate treatment in episodic and chronic migraine patients. METHODS:Language disturbances were recorded on the basis of spontaneous reports of 30 migraine patients treated with topiramate and 2 control groups (20 patients treated with other prophylactic drugs and 20 patients without prophylactic treatment) and were explored with neuropsychological tests. Psychiatric comorbidity was assessed using Zung Anxiety and Depression Scales. RESULTS:Language disturbances were referred by 26.7% (n=8) of patients during topiramate treatment but by none of the patients in the 2 control groups. All patients in the topiramate group had a worse performance on all tests compared to patients of the 2 control groups. Moreover, in the topiramate group, patients with referred language disturbances had higher scores for all neuropsychological test variables, indicative of a worse performance. Some language functions (Trail Making Tests A and B) seemed to be influenced by the concomitant presence of psychiatric comorbidities, particularly anxiety and depression. CONCLUSION:It can be hypothesized that a disorder such as migraine, which involves numerous cortical and subcortical circuits implicated in the transmission and behavioral and emotional processing of pain, represents a facilitated substrate for the occurrence of language disturbances due to topiramate. This could be the expression of a more generalized impairment of cognitive processing. These aspects should be investigated in prospective studies involving larger migraine patient samples.
journal_name
Headachejournal_title
Headacheauthors
Coppola F,Rossi C,Mancini ML,Corbelli I,Nardi K,Sarchielli P,Calabresi Pdoi
10.1111/j.1526-4610.2007.00860.xsubject
Has Abstractpub_date
2008-01-01 00:00:00pages
86-94issue
1eissn
0017-8748issn
1526-4610pii
HED860journal_volume
48pub_type
杂志文章相关文献
HEADACHE文献大全abstract：OBJECTIVE:To assess the efficacy of melatonin as a preventive therapy for hemicrania continua in a larger population of patients than has previously been studied. BACKGROUND:Hemicrania continua is defined by its sensitivity to indomethacin. Rarely can patients be fully tapered off indomethacin without headache recurre...
journal_title：Headache
pub_type： 杂志文章
doi：10.1111/head.12489
更新日期：2015-03-01 00:00:00
abstract：OBJECTIVE:To determine the pharmacological profile of frovatriptan. BACKGROUND:Frovatriptan is a new 5-HT(1B/1D) agonist developed for the treatment of migraine. METHODS:Pharmacological studies were performed using in vitro and in vivo techniques. RESULTS:Radioligand-binding studies showed that frovatriptan has a hi...
journal_title：Headache
pub_type： 杂志文章
doi：10.1046/j.1526-4610.42.s2.2.x
更新日期：2002-04-01 00:00:00
abstract：OBJECTIVE:To examine circadian and menstrual patterns of migraine frequency in order to identify properties of the putative migraine generator. METHODS:Analysis of circadian and menstrual migraine attack frequency distributions, using between-interval differences as estimates, at each time point, of the derivative of ...
journal_title：Headache
pub_type： 杂志文章
doi：10.1111/j.1526-4610.2005.05134.x
更新日期：2005-07-01 00:00:00
abstract：OBJECTIVE:There is very little literature surrounding the prophylactic use of zonisamide in cluster headaches. The study aims to evaluate the effectiveness of zonisamide for prophylaxis of cluster headache in patients with chronic or episodic cluster headache. BACKGROUND:Both chronic and episodic cluster headaches are...
journal_title：Headache
pub_type： 杂志文章
doi：10.1111/head.13546
更新日期：2019-06-01 00:00:00
abstract：BACKGROUND:In Ontario, approximately $3.8 billion is spent annually on publicly funded drug programs. The annual growth in Ontario Public Drug Program (OPDP) expenditure has been limited to 1.2% over the course of 3 years. Concurrently, the Ontario Drug Policy Research Network (ODPRN) was appointed to conduct drug clas...
journal_title：Headache
pub_type： 杂志文章,评审
doi：10.1111/head.12585
更新日期：2015-07-01 00:00:00
abstract：BACKGROUND AND OBJECTIVES:The objective of this study was to investigate the prevalence and sociodemographic characteristics of headaches among Turkish adolescents aged 12 to 17 years old in Bursa province of Turkey. METHODS:A multistep, stratified, cluster sampling method was used for subject selection. The estimated...
journal_title：Headache
pub_type： 杂志文章
doi：10.1111/j.1526-4610.2006.00362.x
更新日期：2006-04-01 00:00:00
abstract：BACKGROUND:It has been suggested that homocysteine (Hcy) and the 5'-10'-methylenetetrahydrofolate reductase (MTHFR) C677T variant are implicated in the pathogenesis of migraine. Homocysteine has the potential to damage endothelium and accelerate atherosclerosis. Genetic factors such as the MTHFR C677T polymorphism, and...
journal_title：Headache
pub_type： 杂志文章
doi：10.1111/j.1526-4610.2009.01484.x
更新日期：2010-01-01 00:00:00
abstract：:Pain has been considered as part of a defensive strategy whose specific role is to signal an immediate active danger to the organism. This definition fits well for acute pain. It does not work well, however, for chronic pain that is maintained even in absence of an ongoing, active threat. Currently, acute and chronic ...
journal_title：Headache
pub_type： 杂志文章,评审
doi：10.1111/j.1526-4610.2012.02244.x
更新日期：2012-10-01 00:00:00
abstract：OBJECTIVE:To characterize adult patients with episodic migraine who achieved 100% response to galcanezumab treatment. BACKGROUND:Galcanezumab is a humanized monoclonal antibody that selectively binds to the calcitonin gene-related peptide (CGRP) and has demonstrated efficacy in reducing migraine headache days (MHD) in...
journal_title：Headache
pub_type： 杂志文章,随机对照试验
doi：10.1111/head.13427
更新日期：2018-10-01 00:00:00
abstract：:A mild electric shock applied to the lower lip was used to elicit reliable evoked potentials from the trigeminal nerve in 20 normal young adults. The wave forms were morphologically similar to those observed with invasive procedures. No substantial differences for either the right or left side of stimulation, recordin...
journal_title：Headache
pub_type： 杂志文章
doi：10.1111/j.1526-4610.1990.hed3011696.x
更新日期：1990-11-01 00:00:00
abstract：:In order to evaluate the effect of non-pharmacological treatment on menstrual and non-menstrual migraine headache (HA), 2 studies have been conducted. In Study 1 which was a retrospective examination of between group reactions to non-drug treatments, 37 self-defined menstrual migraineurs and 62 non-menstrual migraineu...
journal_title：Headache
pub_type： 杂志文章
doi：10.1111/j.1526-4610.1992.hed3204197.x
更新日期：1992-04-01 00:00:00
abstract：:A multicenter 3-year follow-up study was carried out on young patients with headache referred to tertiary headache centers or pediatric clinics. Three years after the first examination in 1993, 442 (of an original sample of 719) young outpatients with headache (226 females and 216 males) were re-examined. The diagnost...
journal_title：Headache
pub_type： 杂志文章,多中心研究
doi：10.1046/j.1526-4610.1999.3910737.x
更新日期：1999-11-01 00:00:00
abstract：:Within- and between-study heterogeneity impede identification of valid primary headache biomarkers. Homogenous subgroup identification and investigation of differential biochemical profiles and networks within and across headache categories, based on statistical techniques, might promote biomarker discovery. When stud...
journal_title：Headache
pub_type： 杂志文章,评审
doi：10.1111/head.13499
更新日期：2019-05-01 00:00:00
abstract：BACKGROUND:Many migraineurs report attack "triggers," but relatively few published data exist regarding the relative prevalences of individual triggers, variations related to gender, duration of migraine or migraine subtype, or the existence of any regional variations in the prevalences and distributions of triggers. ...
journal_title：Headache
pub_type： 杂志文章
doi：10.1111/j.1526-4610.2010.01753.x
更新日期：2010-09-01 00:00:00
abstract：OBJECTIVE:This study evaluated the effectiveness of a single fixed-dose tablet of sumatriptan 85 mg/naproxen sodium 500 mg (sumatriptan-naproxen) using a very early treatment paradigm in migraine patients whose attacks were historically accompanied by cutaneous allodynia. BACKGROUND:Evidence suggests that allodynic mi...
journal_title：Headache
pub_type： 临床试验,杂志文章
doi：10.1111/j.1526-4610.2011.01992.x
更新日期：2012-01-01 00:00:00
abstract：:The majority of research conducted on headache has utilized cross-sectional designs which preclude the examination of dynamic factors and principally rely on group-level effects. The present article describes the application of an individual-oriented process model using time-series analytical techniques. The blending ...
journal_title：Headache
pub_type： 杂志文章
doi：10.1111/j.1526-4610.2005.05095.x
更新日期：2005-05-01 00:00:00
abstract：OBJECTIVE:Migraine is associated with several important visual symptoms, during both acute attacks and headache-free intervals. The purpose of this investigation was to use validated vision-related quality of life instruments to assess the effect of migraine on visual quality of life. BACKGROUND:Many migraineurs exper...
journal_title：Headache
pub_type： 杂志文章
doi：10.1111/head.13330
更新日期：2018-07-01 00:00:00
abstract：:Unilateral hairlike discoloration of the tongue is described in a patient with ipsilateral mandibular division trigeminal neuralgia. This unusual physical sign coincided with the patient's painful trigger zone and was attributed to hypertrophy of keratinized filiform papillae, where guarded avoidance of mechanical sti...
journal_title：Headache
pub_type： 杂志文章
doi：10.1111/j.1526-4610.2004.04173.x
更新日期：2004-10-01 00:00:00
abstract：OBJECTIVE:To determine whether headache disorders are a risk factor for the development of new onset hypothyroidism. BACKGROUND:Past studies have reported associations between headache disorders and hypothyroidism, but the directionality of the association is unknown. METHODS:This was a longitudinal retrospective coh...
journal_title：Headache
pub_type： 杂志文章
doi：10.1111/head.12943
更新日期：2017-01-01 00:00:00
abstract：BACKGROUND:Zonisamide, a sulfonamide analog, is an antiepileptic drug with mechanisms of action similar to topiramate. Because of its pharmacodynamic and pharmacokinetics profiles, zonisamide is also potentially suitable for migraine prevention. METHODS:Tolerability and effectiveness of zonisamide for migraine prophyl...
journal_title：Headache
pub_type： 杂志文章
doi：10.1111/j.1526-4610.2010.01842.x
更新日期：2011-02-01 00:00:00
abstract：:Discrimination toward people living with migraine and other headache disorders is widespread and socially accepted. Stigma toward these diseases is both a manifestation of these discriminatory attitudes and a sustainer of them. For those living with migraine and headache disorders, stigma limits the full expression of...
journal_title：Headache
pub_type： 杂志文章
doi：10.1111/head.13913
更新日期：2020-10-01 00:00:00
abstract：:Subarachnoid hemorrhage as a complication of acupuncture has been reported in only a few cases. We report another case and discuss the implications of subarachnoid hemorrhage following acupuncture. Although acupuncture has traditionally been thought to be relatively safe, physicians should be aware that it may be a ca...
journal_title：Headache
pub_type： 杂志文章
doi：10.1111/j.1526-4610.2008.01139.x
更新日期：2008-09-01 00:00:00
abstract：OBJECTIVE:To determine (1) the clinical course of a sample of chronic migraine patients with drug overuse 6 and 12 months following in-patient treatment and (2) whether functional impairment, assessed by the Migraine Disability Assessment (MIDAS) questionnaire, improved upon treatment. BACKGROUND:Patients with chronic...
journal_title：Headache
pub_type： 杂志文章
doi：10.1111/j.1526-4610.2004.04127.x
更新日期：2004-07-01 00:00:00
abstract：:The treatment of migraine was transformed in 1992 with the introduction of the first triptan-based therapy, subcutaneous (SC) sumatriptan. SC sumatriptan has high efficacy and a rapid onset of action compared with other available triptans and formulations presumably because of its short Tmax, high Cmax, and avoidance ...
journal_title：Headache
pub_type： 杂志文章,评审
doi：10.1111/head.12183
更新日期：2013-09-01 00:00:00
abstract：OBJECTIVE:To investigate whether intravenously infused provokes migraine aura and migraine headache in migraine patients with aura. BACKGROUND:Migraine with aura has been associated with endothelial dysfunction and increased stroke risk. The initiating mechanism of migraine aura symptoms is not known. Experimental pro...
journal_title：Headache
pub_type： 杂志文章
doi：10.1111/head.13753
更新日期：2020-04-01 00:00:00
abstract：BACKGROUND:Mechanical compression of the trigeminal root by an artery is thought to cause trigeminal neuralgia. The 5-HT(1B/1D) receptor agonist may inhibit neurogenic inflammation and vasodilation near the irritated trigeminal root. OBJECTIVE:To examine the effectiveness of a 5-HT(1B/1D) receptor agonist, sumatriptan...
journal_title：Headache
pub_type： 杂志文章,随机对照试验
doi：10.1111/j.1526-4610.2006.00405.x
更新日期：2006-04-01 00:00:00
abstract：OBJECTIVE:Ophthalmoplegic migraine (OM) is a rare disorder characterized by recurrent oculomotor nerve palsy in children, following migraine headaches. We report 62 adults, seen consecutively, who developed acute ophthalmoplegia with severe attacks of migraine over a 10-year (1996-2005) period. An overwhelming majority...
journal_title：Headache
pub_type： 杂志文章
doi：10.1111/j.1526-4610.2009.01405.x
更新日期：2009-06-01 00:00:00
abstract：BACKGROUND:Several studies suggest an association between migraine and juvenile stroke. Because of some shortcomings, we designed another case-control study of a homogenous group of patients with juvenile cerebral ischemia. This study is part of a larger German epidemiological research project on the association of mig...
journal_title：Headache
pub_type： 杂志文章
doi：10.1046/j.1526-4610.2003.03023.x
更新日期：2003-02-01 00:00:00
abstract：BACKGROUND:Eletriptan is a potent 5-HT(1B/1D) agonist with proven efficacy in the acute treatment of migraine in adults. OBJECTIVE:To evaluate the efficacy and tolerability of eletriptan 40 mg versus placebo in adolescent patients (aged 12-17). METHODS:A multicenter, double-blind, parallel-group, placebo-controlled t...
journal_title：Headache
pub_type： 杂志文章,多中心研究,随机对照试验
doi：10.1111/j.1526-4610.2007.00755.x
更新日期：2007-04-01 00:00:00
abstract：:Many patients with migraine believe weather is a trigger for their headaches. The objective of this study was to determine if very low frequency sferics, pulse-shaped electromagnetic fields originating from atmospheric discharges (lightning), are precipitating factors. The occurrence of sferics impulses is characteriz...
journal_title：Headache
pub_type： 杂志文章
doi：
更新日期：2001-10-01 00:00:00
